早期非小细胞肺癌的免疫疗法:一个系统审查
Jingyi Gao1, Chao Zhang2, Zhigang Wei3
1Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, Shandong Province, China.
Journal of cancer research and therapeutics
|September 7, 2023
概括
免疫疗法改变了肺癌的治疗方法,在早期非小细胞肺癌 (NSCLC) 中显示出前景. 需要进一步的研究来澄清其在NSCLC的辅助和新辅助环境中的作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因之一.
- 免疫疗法,特别是免疫检查点抑制剂,已经彻底改变了高级非小细胞肺癌 (NSCLC) 的治疗范式.
- 目前的指导方针支持在NSCLC的各种环境中进行免疫治疗,包括转移性,局部晚期和可切除疾病.
研究的目的:
- 审查目前的证据和正在进行的关于免疫治疗早期非小细胞肺癌的研究.
- 讨论免疫疗法作为新辅助和辅助治疗早期NSCLC的疗效.
- 探索包括生物标志物,不良事件和未来方向在内的关键方面.
主要方法:
- 临床前和临床研究的文献综述.
- 分析随机对照试验 (RCT) 和现实世界的证据数据.
- 讨论与免疫治疗相关的新兴生物标志物和毒性概况.
主要成果:
- 免疫检查点抑制剂在晚期NSCLC中表现出显著的疗效.
- 新辅助和辅助免疫治疗在早期NSCLC中的作用正在积极调查中.
- 生物标志物和与免疫相关的不良事件的管理对于优化治疗至关重要.
结论:
- 免疫疗法具有显著的潜力,可以改善早期NSCLC的结果.
- 进一步的研究和正在进行的临床试验对于建立新辅助和辅助免疫治疗的最佳策略至关重要.
- 基于生物标志物的个性化治疗方法和仔细的毒性管理是未来进步的关键.
相关概念视频
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:30Cancer Vaccines
399
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
399